Antibody Drug Conjugates Market By Drug Type (Monomethyl Auristatin E (MMAE), Monomethyl Auristatin F (MMAF), Maytansinoids (DM1, DM4), Calicheamicin, Duocarmycin, Pyrrolobenzodiazepine (PBD), Doxorubicin Derivatives, Others), By Target Antigen (HER2, CD30, CD33, CD22, TROP-2, Nectin-4, BCMA, CD79b, EGFR, Others), By Technology (Chemical Conjugation, Site-Specific Conjugation, Polymer-Based Conjugation, Click Chemistry, Liposomal Delivery), By Application (Breast Cancer, Lymphoma, Leukemia, Lung Cancer, Urothelial Cancer, Ovarian Cancer, Gastric Cancer, Others), By End-User (Hospitals, Specialty Cancer Centers, Research Institutes, Ambulatory Surgical Centers (ASCs)), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025–2035.
Published Date: May 2025 | Report ID: MI2680 | 220 Pages
Report Coverage:
By Drug Type
- Monomethyl Auristatin E (MMAE)
- Monomethyl Auristatin F (MMAF)
- Maytansinoids (DM1, DM4)
- Calicheamicin
- Duocarmycin
- Pyrrolobenzodiazepine (PBD)
- Doxorubicin Derivatives
- Others
By Target Antigen
- HER2
- CD30
- CD33
- CD22
- TROP-2
- Nectin-4BCMACD79b
- EGFR
- Others
By Technology
- Chemical Conjugation
- Site-Specific Conjugation
- Polymer-Based Conjugation
- Click Chemistry
- Liposomal Delivery
By Application
- Breast Cancer
- Lymphoma
- Leukemia
- Lung Cancer
- Urothelial Cancer
- Ovarian Cancer
- Gastric Cancer
- Others
By End User
- Hospitals
- Specialty Cancer Centers
- Research Institutes
- Ambulatory Surgical Centers (ASCs)
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Pfizer Inc.
- Johnson & Johnson
- AbbVie Inc.
- Merck & Co., Inc.
- Roche Holding AG
- AstraZeneca PLC
- Bristol Myers Squibb
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc (GSK)
- Eli Lilly and Company
- Novo Nordisk A/S
- Amgen Inc.
- Gilead Sciences, Inc.
- Bayer AG
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.